Comparative efficacy and safety of super-bioavailable itraconazole-130 mg once daily in obese and non-obese patients of glabrous tinea

• Auteurs principaux: Manjunath Shenoy (Auteur), Abhishek De (Auteur), Bela Shah (Auteur), Anupam Das (Auteur), Abir Saraswat (Auteur), Koushik Lahiri (Auteur), Dhiraj Dhoot (Auteur)
• Format: Livre
• Publié: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background: Obesity is considered one of the risk factors for dermatophytosis and warrants systemic therapy. Itraconazole is the most commonly used antifungal, but owing to pharmacokinetic challenges, super-bioavailable itraconazole (SITZ) was approved globally, recently. For the management of derma...